Chronic type 2 diabetes reduces the integrity of the blood-brain barrier by reducing tight junction proteins in the hippocampus

Journal of Veterinary Medical Science

Volumn 78, Issue 6, 2016, Pages 957-962

  Yoo, Dae Young ^a   Yim, Hee Sun ^b   Jung, Hyo Young ^a   Nam, Sung Min ^a   Kim, Jong Whi ^a   Choi, Jung Hoon ^c   Seong, Je Kyung ^a   Yoon, Yeo Sung ^a   Kim, Dae Won ^b   Hwang, In Koo ^a  

^a Seoul National University   (South Korea)

^b Gangneung Wonju National University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Blood brain barrier; Hippocampus; Tight junction; Type 2 diabetes

Indexed keywords

CLAUDIN 5; CLDN5 PROTEIN, RAT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; OCCLUDIN; OCLN PROTEIN, RAT; PROTEIN ZO1; TIGHT JUNCTION PROTEIN; TJP1 PROTEIN, RAT;

ANALYSIS; ANIMAL; BLOOD BRAIN BARRIER; CHEMISTRY; COMPLICATION; FEMALE; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; WESTERN BLOTTING; ZUCKER RAT;

ANIMALS; BLOOD GLUCOSE; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CLAUDIN-5; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HIPPOCAMPUS; MALE; OCCLUDIN; RATS; RATS, ZUCKER; TIGHT JUNCTION PROTEINS; ZONULA OCCLUDENS-1 PROTEIN;

EID: 85011117056     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.15-0589     Document Type: Article

References (44)

1. Acharya, N. K., Levin, E. C., Clifford, P. M., Han, M., Tourtellotte, R., Chamberlain, D., Pollaro, M., Coretti, N. J., Kosciuk, M. C., Nagele, E. P., Demarshall, C., Freeman, T., Shi, Y., Guan, C., Macphee, C. H., Wilensky, R. L. and Nagele, R. G.2013. Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib. J. Alzheimers Dis. 35: 179–198. [Medline]
2. Celik, S. and Erdogan, S.2008. Caffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced by diabetes in rats. Mol. Cell. Biochem. 312: 39–46. [Medline] [CrossRef]
3. Chehade, J. M., Haas, M. J. and Mooradian, A. D.2002. Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression. Neurochem. Res. 27: 249–252. [Medline] [CrossRef]
4. Cheng, G., Huang, C., Deng, H. and Wang, H.2012. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern. Med. J. 42: 484–491. [Medline] [CrossRef]
5. Deli, M. A., Descamps, L., Dehouck, M. P., Cecchelli, R., Joó, F., Abrahám, C. S. and Torpier, G.1995. Exposure of tumor necrosis factor-α to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J. Neurosci. Res. 41: 717–726. [Medline] [CrossRef]
6. Didier, N., Romero, I. A., Créminon, C., Wijkhuisen, A., Grassi, J. and Mabondzo, A.2003. Secretion of interleukin-1β by astrocytes mediates endothelin-1 and tumour necrosis factor-α effects on human brain microvascular endothelial cell permeability. J. Neurochem. 86: 246–254. [Medline] [CrossRef]
7. Dietrich, W. D., Alonso, O. and Busto, R.1993. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 24: 111–116. [Medline] [CrossRef]
8. Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., Tsukita, S. and Tsukita, S.1993. Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 123: 1777–1788. [Medline] [CrossRef]
9. Hawkins, B. T. and Egleton, R. D.2006. Fluorescence imaging of blood-brain barrier disruption. J. Neurosci. Methods 151: 262–267. [Medline] [CrossRef]
10. Hawkins, B. T., Lundeen, T. F., Norwood, K. M., Brooks, H. L. and Egleton, R. D.2007. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50: 202–211. [Medline] [CrossRef]
11. Hill, R. E. and Williams, P. E.2004. Perineurial cell basement membrane thickening and myelinated nerve fibre loss in diabetic and nondiabetic peripheral nerve. J. Neurol. Sci. 217: 157–163. [Medline] [CrossRef]
12. Hölscher, C.2011. Diabetes as a risk factor for Alzheimer’s disease: insulin signalling impairment in the brain as an alternative model of Alzheimer’s disease. Biochem. Soc. Trans. 39: 891–897. [Medline] [CrossRef]
13. Horel, J. A.1978. The neuroanatomy of amnesia. A critique of the hippocampal memory hypothesis. Brain 101: 403–445. [Medline] [CrossRef]
14. Huber, J. D., VanGilder, R. L. and Houser, K. A.2006. Streptozotocin- induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am. J. Physiol. Heart Circ. Physiol. 291: H2660–H2668. [Medline] [CrossRef]
15. Hwang, I. K., Choi, J. H., Nam, S. M., Park, O. K., Yoo, D. Y., Kim, W., Yi, S. S., Won, M. H., Seong, J. K. and Yoon, Y. S.2014. Activation of microglia and induction of pro-inflammatory cytokines in the hippocampus of type 2 diabetic rats. Neurol. Res. 36: 824–832. [Medline] [CrossRef]
16. Hwang, I. K., Yi, S. S., Kim, Y. N., Kim, I. Y., Lee, I. S., Yoon, Y. S. and Seong, J. K.2008. Reduced hippocampal cell differentiation in the subgranular zone of the dentate gyrus in a rat model of type II diabetes. Neurochem. Res. 33: 394–400. [Medline] [CrossRef]
17. IDF diabetes atlas update. 2013. http://www.idf.org/diabetesatlas/ introduction
18. Idris, I., Gray, S. and Donnelly, R.2004. Protein kinase C-β inhibition and diabetic microangiopathy: effects on endothelial permeability responses in vitro. Eur. J. Pharmacol. 485: 141–144. [Medline] [CrossRef]
19. Itoh, M., Furuse, M., Morita, K., Kubota, K., Saitou, M. and Tsukita, S.1999. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J. Cell Biol. 147: 1351–1363. [Medline] [CrossRef]
20. Kamada, H., Yu, F., Nito, C. and Chan, P. H.2007. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase- 9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke 38: 1044–1049. [Medline] [CrossRef]
21. Kanoski, S. E., Zhang, Y., Zheng, W. and Davidson, T. L.2010. The effects of a high-energy diet on hippocampal function and blood-brain barrier integrity in the rat. J. Alzheimers Dis. 21: 207–219. [Medline]
22. Kniesel, U. and Wolburg, H.2000. Tight junctions of the blood-brain barrier. Cell. Mol. Neurobiol. 20: 57–76. [Medline] [CrossRef]
23. Marioni, R. E., Strachan, M. W., Reynolds, R. M., Lowe, G. D., Mitchell, R. J., Fowkes, F. G., Frier, B. M., Lee, A. J., Butcher, I., Rumley, A., Murray, G. D., Deary, I. J. and Price, J. F.2010. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 59: 710–713. [Medline] [CrossRef]
24. Min, L. J., Mogi, M., Shudou, M., Jing, F., Tsukuda, K., Ohshima, K., Iwanami, J. and Horiuchi, M.2012. Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of bloodbrain barrier impairment and cognitive decline in type 2 diabetic mice. Hypertension 59: 1079–1088. [Medline] [CrossRef]
25. Mogi, M. and Horiuchi, M.2011. Neurovascular coupling in cognitive impairment associated with diabetes mellitus. Circ. J. 75: 1042–1048. [Medline] [CrossRef]
26. Mooradian, A. D.1997. Central nervous system complications of diabetes mellitus—a perspective from the blood-brain barrier. Brain Res. Brain Res. Rev. 23: 210–218. [Medline] [CrossRef]
27. Moran, C., Phan, T. G., Chen, J., Blizzard, L., Beare, R., Venn, A., Münch, G., Wood, A. G., Forbes, J., Greenaway, T. M., Pearson, S. and Srikanth, V.2013. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 36: 4036–4042. [Medline] [CrossRef]
28. Morrison, J. H. and Hof, P. R.2002. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer’s disease. Prog. Brain Res. 136: 467–486. [Medline] [CrossRef]
29. Pasquier, F., Boulogne, A., Leys, D. and Fontaine, P.2006. Diabetes mellitus and dementia. Diabetes Metab. 32: 403–414. [Medline] [CrossRef]
30. Paxinos, G. and Watson, C.2007. The Rat Brain in Stereotaxic Coordinates. Elsevier Academic Press, Amsterdam
31. Peterson, R. G., Shaw, W. N., Neel, M. A., Little, K. A. and Eichberg, J.1990. Zucker diabetic fatty rat as a model for noninsulin- dependent diabetes mellitus. ILAR J. 32: 16–19. [Cross- Ref]
32. Roberts, R. O., Knopman, D. S., Przybelski, S. A., Mielke, M. M., Kantarci, K., Preboske, G. M., Senjem, M. L., Pankratz, V. S., Geda, Y. E., Boeve, B. F., Ivnik, R. J., Rocca, W. A., Petersen, R. C. and Jack, C. R. Jr.2014. Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology 82: 1132–1141. [Medline] [CrossRef]
33. Roy, S. and Sato, T.2000. Role of vascular basement membrane components in diabetic microangiopathy. Drug News Perspect. 13: 91–98. [Medline] [CrossRef]
34. Sakurai, T., Kawashima, S., Satake, S., Miura, H., Tokuda, H. and Toba, K.2014. Differential subtypes of diabetic older adults diagnosed with Alzheimer’s disease. Geriatr. Gerontol. Int. 14 Suppl 2: 62–70. [Medline] [CrossRef]
35. Serlin, Y., Levy, J. and Shalev, H.2011. Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus. Cardiovasc. Psychiatry Neurol. 2011: 609202. [Medline]
36. Starr, J. M., Wardlaw, J., Ferguson, K., MacLullich, A., Deary, I. J. and Marshall, I.2003. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry 74: 70–76. [Medline] [CrossRef]
37. Tsukamoto, T. and Nigam, S. K.1999. Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins. Am. J. Physiol. 276: F737–F750. [Medline]
38. Ueno, M.2007. Molecular anatomy of the brain endothelial barrier: an overview of the distributional features. Curr. Med. Chem. 14: 1199–1206. [Medline] [CrossRef]
39. West, R. K., Ravona-Springer, R., Schmeidler, J., Leroith, D., Koifman, K., Guerrero-Berroa, E., Preiss, R., Hoffman, H., Silverman, J. M., Heymann, A. and Schnaider-Beeri, M.2014. The association of duration of type 2 diabetes with cognitive performance is modulated by long-term glycemic control. Am. J. Geriatr. Psychiatry 22: 1055–1059. [Medline] [CrossRef]
40. Yi, S. S., Hwang, I. K., Kim, D. W., Shin, J. H., Nam, S. M., Choi, J. H., Lee, C. H., Won, M. H., Seong, J. K. and Yoon, Y. S.2011. The chronological characteristics of SOD1 activity and inflammatory response in the hippocampi of STZ-induced type 1 diabetic rats. Neurochem. Res. 36: 117–128. [Medline] [CrossRef]
41. Yoo, D. Y., Chae, J., Jung, H. Y., Yim, H. S., Kim, J. W., Nam, S. M., Kim, D. W., Choi, J. H., Seong, J. K., Yoon, Y. S. and Hwang, I. K.2015. Treadmill exercise is associated with reduction of reactive microgliosis and pro-inflammatory cytokine levels in the hippocampus of type 2 diabetic rats. Neurol. Res. 37: 732–738. [Medline] [CrossRef]
42. Yu, P. K., Yu, D. Y., Cringle, S. J. and Su, E. N.2005. Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats. Curr. Eye Res. 30: 279–290. [Medline] [CrossRef]
43. Zimmet, P., Alberti, K. G. and Shaw, J.2001. Global and societal implications of the diabetes epidemic. Nature 414: 782–787. [Medline] [CrossRef]
44. Zlokovic, B. V.2008. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178–201. [Medline] [CrossRef]